orbimed advisors llc
-
Contact Information
orbimed advisors llc
601 LEXINGTON AVENUE
NEW YORK NY 10022
Business Phone: (212) 739-6400 13F Sector Allocation 03/31/2013
-
13F Activity for 03/31/2013
[1]Market Value: $4,331,192,446 [1]Prior Market Value: $3,504,679,096 New Purchases: 23 stocks Additional Purchases: 44 stocks Sold out of: 17 stocks Reduced holdings in: 26 stocks Top 10 Holdings %: 39.92% [1] - Market Value shown here may differ from what was reported on the actual 13F filing. The market value shown here includes only those securities that the Whalewisdom parsing engine successfully extracted. Value may also be rounded. Please refer to the actual 13F filing for verification. -
13F Subsidiaries/Managers
Subsidiaries/Managers included in latest 13F Name File # Manager # OrbiMed Capital LLC 028-10410 1 -
13F Holdings Summary
Top 13F Holdings on 03/31/2013 Stock % of Portfolio Pfizer Inc. 6.14% Gilead Sciences Inc. 5.9% Amgen Inc. 5.09% Bristol-Myers Squibb Company 3.91% Infinity Pharmaceuticals, Inc. 3.73% Major new positions on 03/31/2013 Stock % of Portfolio ABBVIE INC. 1.9% Insulet Corporation 1.61% SPDR S&P 500 (PUT) 0.9% Humana Inc. (CALL) 0.64% iShares Russell 2000 Index (PUT) 0.44%
View All HoldingsMajor positions closed on 03/31/2013 Stock Prior % of Portfolio Affymax, Inc. 1.4% MAP PHARMACEUTICALS, INC. COM 1.26% SPDR S&P 500 0.61% Express Scripts Inc. (CALL) 0.46% Perrigo Co. 0.35% -
Recent SEC Filings
Recent filings Form 13F-HR 2013-05-15 Form 13F-HR/A 2013-04-17 Form 13F-HR/A 2013-02-22 Form SC 13D/A 2013-02-14 Form 13F-HR 2013-02-14